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Aims: Due to the increasing evidence of shared vulnerabilities between addictive
behaviors and excessive food intake, the concept of food addiction in specific clinical
populations has become a topic of scientific interest. The aim of this study was to validate
the Yale Food Addiction Scale (YFAS) 2.0 in a Spanish sample. We also sought to explore
food addiction and its clinical correlates in eating disorder (ED) and gambling disorder
(GD) patients.
Methods: The sample included 301 clinical cases (135 ED and 166 GD), diagnosed
according to DSM-5 criteria, and 152 healthy controls (HC) recruited from the general
population.
Results: Food addiction was more prevalent in patients with ED, than in patients with
GD and HC (77.8, 7.8, and 3.3%, respectively). Food addiction severity was associated
with higher BMI, psychopathology and specific personality traits, such as higher harm
avoidance, and lower self-directedness. The psychometrical properties of the Spanish
version of the YFAS 2.0 were excellent with good convergent validity. Moreover, it
obtained good accuracy in discriminating between diagnostic subtypes.
Conclusions: Our results provide empirical support for the use of the Spanish YFAS
2.0 as a reliable and valid tool to assess food addiction among several clinical populations
(namely ED and GD). The prevalence of food addiction is heterogeneous between
disorders. Common risk factors such as high levels of psychopathology and low
self-directedness appear to be present in individuals with food addiction.
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INTRODUCTION
Similarities in the biological and psychological factors involved
in substance abuse and pathological overeating have led some
researchers to postulate that addictive processes may underlie
excess food consumption (1–3). Studies have shown that the
neural reward centers triggered by addictive substances (such as
alcohol or drugs), or behavioral addictions, can also be activated
by highly palatable food (4–11). Similar to drugs of abuse, the
intake of macronutrient-rich foods may increase extracelluar
dopamine in neural regions implicated in reward andmotivation,
thereby increasing the likelihood of reward-driven eating in the
absence of homeostatic need (12–15). Likewise, there is evidence
that repeated exposure to sugar-sweetened beverages can lead
to frontostriatal adaptations and behavioral disinhibition (16).
Patients with substance use disorders and behavioral addictions
also report symptoms that are also often found in the context
of eating disorders (EDs) or in individuals with excess weight.
For example, some individuals report that they compulsively
consume highly palatable foods despite trying to cut down on
food intake or that they experience loss of control once they
begin eating certain foods (17). Strong cravings for foods despite
feeling full and spending a disproportionate amount of time to
obtain food are also common occurrences in some ED patient
populations (18, 19). Most importantly, people who present these
symptoms continue overeating even though the consequences of
excess food intake may cause significant functional impairment
in the physical, personal and/or social domains of their life (20).
These behaviors can all be considered within the context of the
impulsive/compulsive spectrum (21), though few studies to date
have placed food addiction within this model.
The Yale Food Addiction Scale (YFAS) (22) was the first
validated instrument to measure addictive-like eating behavior,
commonly referred to as food addiction. This instrument was
based on the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV-TR) (23) criteria for substance dependence
and was adapted to the context of food consumption. Multiple
studies using this questionnaire have verified its psychometric
soundness and validity, and empirical data have linked high
symptom count on the YFAS to: (a) eating related problems,
such as obesity, binge eating disorders, food cravings and poor
response to bariatric surgery (18, 24–27); and (b) altered neural
response (28–30).
The prevalence of food addiction based on YFAS criteria has
been found to range from 11 to 40%, depending on multiple
factors such as the sample origin, participants’ age (higher
prevalence for middle-aged and older samples), sex (higher
incidence in women), or lower socioeconomic level (18, 31–
34). In addition to food addiction being associated with obesity
and binge eating disorder (28, 35, 36), food addiction has also
been observed in some normal-weight individuals who exhibit
bulimic behavior (37). Levels of food addiction symptomatology
appear to respond to psychological interventions, with one study
finding that food addiction levels reduced after a short-term
intervention in patients with bulimia nervosa (38). Interestingly,
recent research has also linked food addiction symptomatology
to gambling disorder (GD), suggesting that these two conditions
may share common risk factors (19, 39, 40). Still, there is lack of
consensus within the scientific community and among clinicians
regarding the proper operational definition of food addiction
(41–44). Some researchers have posited that “eating addiction”
rather than food addiction might be a more accurate designation
due to the fact that evidence regarding the addictive properties of
specific foods is scarce (45).
The YFAS 2.0 was recently developed (46) to coincide with the
new DSM-5 substance-related and addictive disorders (SRAD)
criteria (47). The objective of these SRAD criteria is to assess a
recurrent pattern of abusive consumption that leads to clinically
significant distress. It includes core symptoms such as cognitive
distortions, craving, abstinence and tolerance (47). In order to
maintain consistency with the DSM-5 model of addiction and
to make certain that the YFAS 2.0 reflected these changes, the
updated scale added items regarding craving, merged abuse
and dependence criteria, and used a diagnostic continuum of
severity. Results obtained in the original validation sample of
550 participants showed that the YFAS 2.0 had high internal
consistency, and convergent and discriminant validity (high
scores on the questionnaire were strongly linked to obesity and
binge eating problems) (46). This scale has also been adapted and
validated for German, Italian and French populations (48–50).
The food addiction construct, therefore, seems to share
clinical characteristics with other addiction types, both substance
and behavioral addictions, as well as with eating disorders
(45, 51). However, there is a shortage of studies that aim to
establish in depth a clear phenotype of these clinical populations,
evaluating them together and comparing them with the general
population. In order to establish these phenotypes, it is essential
to assess food addiction levels in these populations, as well
as co-occurring personality traits and psychopathology, given
that all these factors are essential in defining and treating these
different disorders (52). For this reason, the aim of the current
study was to explore the associations of food addiction with
clinically relevant variables such as psychopathology, personality,
and gender in a sample of patients with an eating disorder
(ED), with gambling disorder (GD), and a healthy-weight control
group (HC). Additionally, we sought to analyze the psychometric
properties of the Spanish version of the YFAS 2.0.
MATERIALS AND METHODS
Participants
The sample was recruited between May 2016 and March 2017.
The study sample included three groups: a group of n = 135
treatment-seeking ED patients, a group of n = 166 treatment-
seeking GD patients and a HC group of n = 197 individuals
recruited from the general population. The participants in the
ED and GD groups were consecutively recruited from the Eating
Disorders Unit at Bellvitge University Hospital in Barcelona,
Spain, and the Gambling Disorder Unit at the same hospital.
Patients were diagnosed according to DSM-5 criteria (47) by
licensed clinical psychologists and psychiatrists. Information
regarding the treatment protocols used in the Eating Disorder
and Behavioral Addiction Units are explained in Jiménez-
Murcia et al. (53) and Fernández-Aranda and Turon (54).
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Participants in the HC group were recruited from the same
university hospital setting to guarantee the equivalence of the
geographical origin between study groups. Inclusion criteria for
the clinical groups were (1) fulfilling DSM-5 criteria for GD or
an ED; and, for all participants, (2) being between 18 and 65
years old. Exclusion criteria for all participants included: the
presence of an organic mental disorder, intellectual disability, a
neurodegenerative condition, such as Parkinson’s disease, or an
active psychotic disorder. For the HC group, a lifetime history of
ED or GD was an exclusion criterion.
In the ED group, 26 participants met criteria for anorexia
nervosa (AN, 19.3%), 43 for bulimia (BN, 31.9%), 29 for binge
eating disorder (BED, 21.5%), and 37 for other specified feeding
eating disorder (OSFED, 27.4%). In the GD group, 23 patients
(13.9%) had mild GD severity (4 or 5 DSM-5 criteria), 51 patients
(30.7%) had moderate GD severity (6 to 7 DSM-5 criteria), and
92 subjects (55.4%) had severe GD severity (8 or more DSM-5
criteria).
Table 1 includes a description of the sample
(sociodemographic and clinical measures) stratified by group.
Instruments
Yale Food Addiction Scale Version 2.0 (YFAS 2.0) (46)
This self-report questionnaire consists of 35 items scored on an
eight-level Likert scale (from 0 = never to 7 = every day) and
adapted to assess addictive eating behaviors based on DSM-5
SRAD criteria.
The validated Spanish version of the original YFAS
demonstrated very good psychometric properties (55):
excellent internal consistency for the one single dimension
solution (α = 0.95), good accuracy in differentiating between
the sample origin (ED vs. controls: specificity equal to 97.6%,
sensitivity= 72.8% and area under receiver operating curve AUC
= 0.90), good discriminative capacity in screening for specific
EDs, and convergent validity compared to external measures of
negative affect and depression, general psychopathology, eating
disorder severity, and body mass index.
The Spanish YFAS 2.0 includes additional questions that take
into account DSM-5 SRAD criteria and follows the scoring
guidelines used in the original validation of the YFAS 2.0.
These scoring guidelines produces two measurements: (a) a
continuous symptom count score that reflects the number of
fulfilled diagnostic criteria (ranging from 0 to 11); and (b) a food
addiction threshold based on the number of symptoms (at least
2) and self-reported clinically significant impairment or distress.
This final measurement allows for the binary classification of
food addiction (present vs. absent). Based on the revised DSM-
5 taxonomy, the YFAS 2.0 also provides severity cutoffs for
patients who surpass the threshold for food addiction: mild
(2–3 symptoms), moderate (4–5 symptoms), and severe (6–11
symptoms).
The YFAS 2.0 was translated into Spanish in accordance with
the International Test Commission Guidelines for Translating
and Adapting Tests (56). Bilingual clinical psychologists with
extensive experience in the ED field translated the original
English version into Spanish. This translated Spanish version
was then back-translated by a native English speaker and any
differences between both versions were discussed and resolved
by consensus. The Spanish YFAS Version 2.0 was reviewed
by two other Spanish-speaking clinical psychologists, who had
not been involved in the back-translation procedure. This was
done in order to confirm that the instrument was clear and
understandable for younger populations.
Eating Disorder Inventory-2 (EDI-2) (57)
This multidimensional self-report questionnaire includes 91
items to assess cognitive and behavioral characteristics related
to eating disorders: drive for thinness, body dissatisfaction,
bulimia, ineffectiveness, perfectionism, interpersonal distrust,
interoceptive awareness, maturity fears, asceticism, impulse
regulation, and social insecurity. A global measure of ED severity
can be obtained based on the sum of all the items on the
scale. The Spanish validation of this questionnaire obtained
excellent psychometrical properties as an external global measure
of ED severity (58). Internal consistency for EDI-total scores was
excellent in our sample (α= 0.97).
Diagnostic Questionnaire for Gambling Disorder
According to DSM Criteria (59)
This 19-item questionnaire assesses DSM-IV-TR (23) andDSM-5
(47) diagnostic criteria for GD. Convergent validity with external
measures of gambling severity in the original validation was
very good (r = 0.77 for the sample recruited in the general
population and r = 0.75 for gambling treatment group; (59).
Internal consistency of the Spanish version of the questionnaire
used in this work was also good (α = 0.81 for the general
population and α = 0.77 for gambling treatment samples; (60).
Internal consistency for the study was α= 0.76. A global measure
of GD severity can be obtained based on the sum of all the items
on the scale.
Temperament and Character Inventory-Revised
(TCI-R) (61)
This self-report questionnaire is designed to evaluate personality
traits using 240-items on a five-level Likert scale. It is
structured on seven primary personality dimensions: four
temperamental factors (novelty seeking, harm avoidance, reward
dependence and persistence) and three character dimensions
(self-directedness, cooperativeness and self-transcendence). The
validated Spanish version used in this study has shown very good
internal consistency (Cronbach’s alpha αmean value of 0.87) (62).
Cronbach’s alpha for the TCI-R in the study sample was good to
excellent (between α = 0.78 for novelty seeking to α = 0.89 to
persistence; see Table 1 for the α-values obtained in each TCI-R
scale).
Symptom Checklist Revised (SCL-90-R) (63)
This 90-item self-report questionnaire is widely used for the
measurement of perceived psychopathology. It is structured on
nine first-order dimensions: somatization, obsessive-compulsive,
interpersonal sensitivity, depression, anxiety, hostility, phobic
anxiety, paranoid ideation and psychoticism. A global severity
index is also used as a global distress index (GSI scale). The
Spanish validation of this instrument has shown a mean internal
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TABLE 1 | Sample description.
Eating disorder patients Gambling disorder patients Healthy control participants
n = 135 n = 166 n = 152
n % n % n % χ2 df p
SEX
Females 121 89.6 12 7.2 124 81.6 263.5 2 <0.001
Males 14 10.4 154 92.8 28 18.4
EDUCATION LEVEL
Primary or less 28 22.2 80 52.6 0 0.0 133.6 4 <0.001
Secondary 87 69.0 59 38.8 148 99.3
University 11 8.7 13 8.6 1 0.7
CIVIL STATUS
Single 90 71.4 80 52.6 144 98.0 82.30 4 <0.001
Married or with partner 24 19.0 56 36.8 2 1.4
Separated or divorced 12 9.5 16 10.5 1 0.7
EMPLOYMENT STATUS
Unemployed 30 24.6 55 36.2 33 24.8 6.10 2 0.047
Employed 92 75.4 97 63.8 100 75.2
α Mean SD Mean SD Mean SD F df p
Age (years-old) 31.35 13.66 40.44 13.11 21.21 3.03 118.5 2/450 <0.001
Body mass index (BMI, kg/m2) 26.89 10.17 26.48 4.83 22.12 4.08 22.07 2/450 <0.001
ED severity: EDI-2 total score 0.971 107.91 38.28 − − 33.60 25.93 368.2 1/285 <0.001
GD severity: total DSM-5 criteria 0.756 − − 7.46 1.49 − − − − −
SCL-90-R GSI score 0.982 1.77 0.75 1.19 0.67 0.63 0.46 112.7 2/450 <0.001
TCI-R Novelty seeking 0.776 99.62 16.75 112.56 12.82 99.30 12.16 44.00 2/450 <0.001
TCI-R Harm avoidance 0.892 120.76 18.56 100.22 15.73 98.79 17.89 67.31 2/450 <0.001
TCI-R Reward dependence 0.829 98.13 15.68 99.53 16.44 103.96 14.08 5.59 2/450 0.004
TCI-R Persistence 0.888 106.05 20.99 109.97 19.13 113.86 18.06 5.64 2/450 0.004
TCI-R Self-directedness 0.879 114.20 18.77 127.63 20.75 141.98 16.02 77.16 2/450 <0.001
TCI-R Cooperativeness 0.833 133.62 15.18 128.50 16.61 136.96 14.30 11.62 2/450 <0.001
TCI-R Self-transcendence 0.864 64.76 14.28 62.08 15.16 63.22 13.32 1.22 2/450 0.295
SD, standard deviation; df, degrees of freedom; α, Cronbach’s alpha in the sample; —, The measure is not available for this group.
consistency of α= 0.75 (64). In this study, the GSI score was used
as an external measure to assess the YFAS 2.0 convergent validity.
Cronbach’s alpha for this scale in the sample was excellent
(α= 0.98).
In addition to the assessment battery, ED and GD patients
underwent a semi-structured face-to-face interview to obtain
sociodemographic data (age, education level, employment status,
and civil status) and other clinical measures (age of disorder
onset and disorder duration). This interviewing process has been
described previously (53, 54).
Ethics
This study was carried out in accordance with the latest version
of the Declaration of Helsinki. The Ethics Committee of Bellvitge
University Hospital (Barcelona, Spain) approved the study, and
signed informed consent was obtained from all final participants.
Data Analyses
Data analyses were carried out withMplus8 (65) and Stata15 (66).
Confirmatory Factor Analysis (CFA) assessed the single factor
solution for the YFAS 2.0, defining each criterion as categorically
dichotomous, and using robust weighted least squared estimator
(WLSMV) and delta parameterization. Following previous
validation studies for the YFAS, the item measuring impairment-
distress was not considered in the CFA since this is a criterion
of clinical significance as a whole. Due to the heterogeneity
of the sample of the study, the invariance by group (HC,
ED, and GD) and sex (male and female) were tested by
fitting CFA multi-group models. Goodness-of-fit was considered
adequate according to Barrett (67): Root Mean Square Error of
Approximation RMSEA < 0.10, Bentler’s Comparative Fit Index
CFI > 0.90, Tucker-Lewis Index TLI > 0.90, and Weighted Root
Mean Square Residual WRMR < 1. Internal consistency was
measured through Cronbach’s alpha (α, considering α > 0.80 to
be adequate).
In this study, different dimensional and categorical measures
for the YFAS 2.0 were analyzed. Firstly, the YFAS 2.0 dimensional
symptom count, which measures the 11 DSM-5 SRAD criteria
(raw scores are in the range of 0–11). And second, the two
categorical classifications based on the dimensional symptom
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count: (a) a threshold for food addition (present for individuals
with at least 2 symptoms plus self-reported clinically significant
impairment or distress, and absent for participants who did not
meet these criteria); and (b) for patients who met food addiction
threshold, a categorical variable classified food addiction severity
(mild for participants with 2 or 3 symptoms, moderate for
individuals with 4–5, and severe for patients with at least 6
symptoms).
The capacity of the dimensional YFAS 2.0 symptom count to
discriminate between the groups was tested through analysis of
variance (ANOVA), and the capacity of the YFAS 2.0 categorical
classifications to discriminate between the diagnostic subtypes
was tested through chi-square tests (χ2).
The convergent validity of the YFAS 2.0 with external
measures (BMI and EDI-2), personality (TCI-R) and
psychopathology scores (SCL-90R GSI) was estimated through
Pearson’s correlation (r, with |r |≥ 0.30 considered evidence of a
relevant association; (68).
Receiver Operating Characteristics (ROC) methodology
assessed the accuracy of the YFAS 2.0 to differentiate between the
diagnostic subtypes (ED, GD, and HC). ROC analysis is usually
employed in clinical epidemiology and research areas to quantify
the accuracy of screening tests and to differentiate between
patient states (typically referred to as diseased and non-diseased)
(69). The area under the ROC curve (AUC) was estimated as a
global measure of the global accuracy-validity of the YFAS 2.0
across all the cutoff points, compared with the external standard
of ED group vs. HC group. In these subsamples, the accuracy of
food addiction threshold was estimated through the sensitivity
(Se) and specificity (Sp) coefficients, and through the Cohen’s-
kappameasuring the agreement with the external standard of this
work (κ, considering κ > 0.40 to be moderate, κ > 0.60 to be
good, and κ > 0.80 to be excellent) (70).
Other statistical analysis in the study included χ2 procedures
to compare the proportions obtained for categorical variables,
and ANOVA to compare means obtained for quantitative
variables between groups. Estimation of effect size for proportion
comparisons and mean comparison was based on Cohen-d
coefficient, considering |d| < 0.20 to be null effect size for, |d| >
0.20 to be low effect size, |d|> 0.50 to be fair-moderate effect size,
and |d| > 0.80 to be good-high effect size (68).
RESULTS
Food Addiction Prevalence and Symptom
Count Among the Groups
Table 2 includes the distribution of the YFAS 2.0 symptom count
in each group and a comparison between them. In the ED group,
food addiction symptom count levels were higher in comparison
to both GD and HC groups. GD patients obtained higher
proportion rates compared to HC for some criteria (although
effect sizes were low): consume more than planned, use despite
the physical/emotional or interpersonal effects and failure in role
obligations. The prevalence of participants whomet the threshold
for food addiction was statistically equal for HC and GD (3.3
and 7.8%, respectively), and very low compared to the prevalence
registered for the ED group (77.8%). Considering the YFAS 2.0
symptom count, the means registered in the three groups were
statistically different (0.84 for HC, 1.43 for GD and 6.76 for ED),
with the effect size not being relevant when comparing HC with
GD patients. Figure 1 contains the box-plots for the symptom
count and the bar-charts for those who met the food addiction
threshold.
Food Addiction Categories and Relevant
Clinical and Personality Measures
The first part of Table 3 contains the capacity of the YFAS
2.0 screening threshold to discriminate the clinical measures
used in the study, that is, the comparison of the mean
clinical scores (BMI, EDI-2 total scores, SCL-90-R, and TCI-
R scores) between participants in the food addiction-present
vs. absent binary scores. All the means registered in the food
addiction =positive/present screening were statistically different
than those registered in the food addiction =negative/absent
screening, except for in the personality traits novelty seeking,
cooperativeness and self-transcendence. Means in the food
addiction group were statistically higher for BMI, EDI-2, GSI and
harm avoidance, and lower for reward dependence, persistence
and self-directedness. The second part of Table 3 contains the
means registered in the clinical measures of the study for the
groups defined according to YFAS 2.0 food addiction severity
levels (mild, moderate and severe). Food addiction with mild
severity obtained lower scores than moderate and severe food
addiction levels in BMI and the EDI-2 and GSI scales; mild food
addiction also registered lower means compared to severe food
addiction in harm avoidance and persistence traits.
Associations Between the YFAS 2.0
Symptom Count Levels and External
Measures
Table 4 includes the correlation matrix estimating the
associations between the YFAS 2.0 symptom count levels and the
participants’ age, BMI, and EDI-2 total scores, psychopathology
(SCL-90-R GSI scale) and personality traits (TCI-R dimensions).
These results indicate that YFAS 2.0 symptom count levels are
positively related to BMI, ED severity, psychopathology (GSI
index), and harm avoidance. However, a negative correlation
between food addiction symptom count levels and self-
directedness was found. No correlation between GD severity
levels and food addiction severity was found.
Accuracy of the YFAS 2.0 as a
Screening/Diagnosis Tool
The YFAS 2.0 symptom count obtained excellent accuracy in
discriminating between HC and the ED group (results in the
ROC analysis reported AUC = 0.904). The YFAS 2.0 diagnosis
also adequately differentiated between participants in the HC and
ED subsamples (Sp = 96.7%, Se = 77.8%, and Cohen’s kappa
measuring agreement was κ= 0.75).
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TABLE 2 | Capacity of the YFAS 2.0 measures to discriminate between groups.
ED GD HC ED vs. GD vs. GD vs.
n = 135 n = 166 n = 152 HC HC ED
YFAS 2.0 criteria n % n % n % p |d| p |d| p |d|
Consumed more than planned 90 66.7 33 19.9 16 10.5 0.001* 1.41† 0.021* 0.26 0.001* 1.07†
Unable to cut down-stop 81 60.0 26 15.7 19 12.5 0.001* 1.14† 0.419 0.09 0.001* 1.03†
Great deal of time spent 87 64.4 27 16.3 24 15.8 0.001* 1.15† 0.908 0.01 0.001* 1.13†
Important activities given up 98 72.6 18 10.8 7 4.6 0.001* 1.95† 0.053 0.24 0.001* 1.61†
Use despite physic-em. effects 90 66.7 20 12.0 8 5.3 0.001* 1.66† 0.039* 0.25 0.001* 1.35†
Tolerance 76 56.3 14 8.4 7 4.6 0.001* 1.36† 0.170 0.16 0.001* 1.19†
Withdrawal 91 67.4 24 14.5 18 11.8 0.001* 1.38† 0.491 0.08 0.001* 1.28†
Craving 82 60.7 25 15.1 6 3.9 0.001* 1.53† 0.001* 0.39 0.001* 1.07†
Failure in role obligation 75 55.6 15 9.0 2 1.3 0.001* 1.51† 0.002* 0.35 0.001* 1.15†
Use despite interpers. effects 64 47.4 23 13.9 9 5.9 0.001* 1.06† 0.009 0.27 0.001* 0.78†
Use physically hazardous situat. 79 58.5 13 7.8 11 7.2 0.001* 1.30† 0.841 0.02 0.001* 1.28†
Impairment or distress 112 83.0 15 9.0 7 4.6 0.001* 2.58† 0.120 0.18 0.001* 2.21†
FOOD ADDICTION
Positive-present 105 77.8 13 7.8 5 3.3 0.001* 2.33† 0.080 0.20 0.001* 2.00†
aSEVERITY
Mild 9 8.6 2 15.4 1 20.0 0.508 0.33 0.814 0.12 0.305 0.21
Moderate 14 13.3 0 0 0 0 0.55† 0.00 0.55†
Severe 82 78.1 11 84.6 4 80.0 0.05 0.13 0.17
YFAS continuous measure Mean SD Mean SD Mean SD P |d| P |d| P |d|
Food addiction symptoms 6.76 3.75 1.43 2.50 0.84 1.86 0.001* 2.00† 0.049* 0.27 0.001* 1.67†
aClassification of severity levels of patients who met the criteria for food addiction.
HC, healthy control; ED, eating disorder; GD, gambling disorder. *Bold, significant comparison (0.05 level); †Bold, effect size in the moderate (|d| > 0.50) to good (|d| > 0.80 range).
FIGURE 1 | Boxplot for YFAS 2.0 symptom count and bar-chart for prevalence of subjects meeting food addiction threshold (whole sample, stratified by group). HC,
healthy control; ED, eating disorder; GD, gambling disorder.
Confirmatory Factor Analysis
Table S1 (supplementary material) contains the complete results
for the CFA analysis. The single factor model obtained adequate
fit in the whole sample: RMSEA = 0.034, CFI = 0.998, TLI =
0.998, and WRMSR = 0.723. All the items reached very high
loadings (above 0.80). The internal reliability coefficient was
excellent (α= 0.94). Multi-group analysis did not have a better fit
to the data assessing the invariance of the questionnaire structure
by group (HC-ED-GD: χ2 = 129.04, df= 106, p= 0.064) and sex
(women-men: χ2 = 51.73, df = 53, p = 0.524). These findings
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TABLE 4 | Pearson’s correlation between the YFAS 2.0 symptom count with
psychological measures.
Total ED GD HC
n = 453 n = 135 n = 166 n = 152
Age (years-old) 0.121 0.250† 0.018 0.135
Body mass index (kg/m2) 0.345† 0.345† 0.342† 0.098
SCL-90R GSI score 0.565† 0.288† 0.318† 0.619†
TCI-R Novelty seeking −0.034 0.189 0.029 0.033
TCI-R Harm avoidance 0.464† 0.253† 0.124 0.280†
TCI-R Reward dependence −0.183 −0.247† −0.057 −0.104
TCI-R Persistence −0.218 −0.251† −0.160 −0.026
TCI-R Self-directedness −0.531† −0.372† −0.334† −0.389†
TCI-R Cooperativeness −0.168 −0.204 −0.302† −0.254†
TCI-R Self-transcendence 0.090 0.064 0.064 0.074
EDI-2 total score 0.368† — 0.658†
GD: total DSM-5 criteria — 0.060 —
HC, healthy control; ED, eating disorder; GD, gambling disorder; —, The measure is not
available for the group. †Bold, effect size into the range moderate (|r| > 0.24) to good (|r|
> 0.30).
suggested that the one dimensional structure was also adequate
to represent the structure of the Spanish YFAS 2.0 for male and
female, ED, GD, and, HC samples.
Table S2 (supplementary) includes the distribution of the
YFAS 2.0 in the study, stratified by the diagnostic subtype and
participants’ sex. Analyses stratified for each group showed that
no statistical differences emerged comparing the means of the
YFAS 2.0 symptom count between men and women in the HC
group (F = 1.12, df = 1/150, p= 0.293) or in the ED group (F =
0.11, df = 1/133, p = 0.747), but it was when comparing sex in
GD (F = 4.14, df = 1/164, p= 0.043).
Comparison of the YFAS 2.0 measures between ED subtypes
obtained significant results for both the number of reported
symptoms (F = 20.45, df = 3/131, p < 0.001) and the presence
of food addiction (χ2 = 14.04, df = 3, p = 0.003) (Figure 2).
Pairwise comparisons for the YFAS 2.0 symptom count between
groups indicated that no difference was present between OSFED
and AN (T = 0.35, df = 131, p = 0.732), nor between BN and
BED groups (T = 0.20, df = 131, p = 0.839). However, OSFED
patients endorsed lower symptom count levels than BN (T =
5.77, df = 131, p < 0.001) and BED patients (T = 5.41, df = 131,
p < 0.001); whereas AN obtained lower symptom count levels
than BN (T = 5.56, df = 131, p < 0.001) and BED patients (T =
5.30, df = 131, p < 0.001).
DISCUSSION
There has been growing scientific and clinical interest on whether
parallels between the symptomatology present in individuals
with substance abuse disorders and excessive food intake can be
made (71). The food addiction construct has received increased
clinical interest in recent years, although is not recognized as a
DSM-5 condition (72, 73). The YFAS 2.0 is the only self-report
questionnaire assessing food addiction, referring to addictive-like
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FIGURE 2 | Boxplot for the YFAS 2.0 symptom count and bar-chart for prevalence of subjects meeting food addiction threshold in the (ED subsample, stratified by
ED subtype). OSFED, other specified feeding eating disorder; AN, anorexia nervosa; BN, bulimia nervosa; BED, binge eating disorder; ED, eating disorder.
eating, based on updated DSM-5 SRAD criteria (46). This tool
has been validated in different languages, such as in German (48),
Italian (50), and French (49). However, this is the first validation
of a Spanish language version of the YFAS 2.0 that has been
carried out to date. This study confirmed the sound psychometric
properties of the Spanish YFAS 2.0. Additionally, we set out
to assess the relevance of clinical measures and food-addiction-
related variables in a large sample including patients who met
criteria for ED or GD, as well as a HC group.
In terms of prevalence, 3.3% of the participants of the HC
group met criteria for the presence of food addiction. This
finding is lower than the prevalence reported in the general
population using previous versions of the YFAS (27) and in the
development of this scale (46), but with similar values reported
in previous version of the YFAS (2.4% in HC) (55). Taking GD
into account, 7.8% of the patients met criteria for the presence
of food addiction. This prevalence is in accordance with a
recent study obtaining similar values using the original YFAS
(19). Finally, regarding ED samples, food addiction prevalence
levels were comparable to those reported using the previous
version of the YFAS (78% of the ED participants in our study
met the food addiction threshold; (18, 55). Additionally, the
results of the current study indicate that the YFAS 2.0 has the
discriminative capacity to differentiate between ED subtypes
(lower food addiction levels were found in OSFED and AN
compared to BN and BED), which is also consistent with
empirical data reported in previous studies (24, 55). In fact, in
our study, the highest percentage of food addiction corresponded
to BN group (24, 74). One can postulate that BN and BED
patients endorsed higher food addiction severity levels due to
the subjective feeling of loss of control and distress that are
characterisitic bingeing episodes (75). The extent to which food
addiction symptoms might be a premorbid condition of ED
symptomatology, or just a consequent factor, could be not be
explored with the present research design (51).
As in other studies, we found that higher scores in food
addiction symptomatology were positively associated with BMI
in ED and GD groups (24). We also found that food addiction
prevalence was associated with higher BMI in subjects from the
general population (50, 76). However, it must be stressed that not
all obese or overweight individuals meet the criteria for “food
addiction.” For example, a study in a sample of obese adolescents
found that just 38% of the sample met the threshold for food
addiction (8). The prevalence found in our adult sample was
very similar to that found in other studies (77). A recent meta-
analysis also indicated that overweight/obese females aged over
35 years may be more predisposed to food addiction, as assessed
by the YFAS (18).While some authors support the food addiction
concept by arguing that it shares clinical and neurological traits
with addictive disorders (46, 78), others state that it merely serves
as an indicator of overeating severity (6).
Numerous similarities between ED and GD have been shown
in terms of personality traits and neuropsychological factors
(39, 79, 80). Moreover, both disorders have been associated with
the presence of food addiction. However, in the present study,
food addiction symptom count levels were higher in the ED
group compared to both GD and HC groups. Likewise, the
prevalence of food addiction was significantly higher in the ED
group in comparison with GD and HC groups. Although several
studies have postulated that food addiction should be defined as
a behavioral addiction due to the striking similarities between
overeating and other behavioral addictions like GD (81, 82), our
findings suggest that food addiction is strongly associated with
ED pathology. However, it is important to bear in mind the
gender differences in the clinical groups featured in this study;
although GD is a condition that mostly affects males (83), when
we consider only women with this condition, the rates of food
addiction increase significantly (19).
The YFAS 2.0 threshold also demonstrated good capacity
to discriminate between the clinical measures employed in the
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study. Overall, BMI and psychopathology levels were higher
in the group with food addiction compared to those not food
addiction meeting criteria. Specifically, participants who met the
threshold for food addiction showed significantly higher scores
in the GSI scale, indicating elevated general psychopathology
levels. Significant differences were also found regarding some
personality traits, participants who presented food addiction
were characterized by higher levels in harm avoidance and lower
self-directedness. These results are in the line with previous food
addiction literature by our group indicating that individuals with
food addiction, regardless of diagnoses tend to have lower levels
of self-directedness (19, 84).
The findings of this study could be used to identify those
individuals who best fit the food addictionmodel. However, more
research is required to determine the efficacy of pharmacological
and psychological approaches in individuals with food addiction.
For example, naltrexone and bupropion have been used for
chronic weightmanagement in some obese adults, and, given that
these medications are used in the treatment of other substance
addictions, it could of interest to know whether patients who
report more addictive-like symptoms respond differently (85).
Psychological treatment could also have a positive impact on
the cognitive processes involved in improving food addiction
symptomatology.
Limitations
The findings of this study must be considered in the context
of its limitations. First, the different groups were unbalanced in
terms of sex and age. Future studies should aim to include more
balanced samples and a control group that is more representative
in terms of sociodemographical factors with respect to the clinical
groups. Second, food addiction was assessed using a self-report
measure which restricts the evaluation of other factors that may
be interfering with the obtained results. Third, clinical groups
are only constituted by treatment-seeking patients. Therefore,
this population is not representative of all individuals with
these problematic behaviors. Finally, in the present validation
individuals without an ED but with overweight/obesity are
underrepresented. Future food addiction studies should attempt
to include subjects that reflect the general population.
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